Follow
Redwood Pharma AB
Spotlight (Sweden)
Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.
Sector:
HEALTH CARE
New issue
Price
7.25 SEK
Subscription period
04 Sep - 23 Sep 2019
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
REDW
SE0008294789
Spotlight
Sweden (SE)
Details of share in Redwood Pharma AB with ticker REDW
Status
Active
Order book id
4142
Amount of instruments
12 499 874
Par value
0.2000
Market cap
Currency
SEK
First trading date
15 Jun 2016
Terms
Type
Price
Pre-money valuation
Time
IPO
9.00 SEK
28.8M SEK
16 May - 27 May 2016
IPO in Redwood Pharma AB
Market
Spotlight
Subscription period
16 May - 27 May 2016
Subscription price
9.00 SEK
Price per share
9.00 SEK
Target to raise
19 800 000 SEK
Types
Pre-money valuation
28 800 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
15 Jun 2016
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
New issue
3.30 SEK
16.5M SEK
01 Jun - 20 Jun 2017
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
01 Jun - 20 Jun 2017
Subscription price
3.30 SEK
Price per share
3.30 SEK
Target to raise
13 200 000 SEK
Types
Share issue
Pre-money valuation
16 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:5. Those who are registered as shareholders of Redwood Pharma on the record date for the Rights Issue receive one (1) unit right for each existing share that the owner holds in the Company. Five (5) unit rights entitle to subscribe for four (4) units. Each unit consists of one (1) newly issued share and one (1) newly issued warrant.
Type
Price
Pre-money valuation
Time
Exercise
10.35 SEK
-
01 Jun - 31 Aug 2017
Option exercise terms for REDW TO 1
Market
Spotlight
Exercise period(s)
01 Jun - 31 Aug 2017
Exercise price
10.35 SEK
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
Exercise
5.52 SEK
-
02 Oct - 16 Oct 2017
Option exercise terms for REDW TO 2
Market
Spotlight
Exercise period(s)
02 Oct - 16 Oct 2017
Exercise price
5.52 SEK
Status
Closed
Issue terms
Type
Price
Pre-money valuation
Time
New issue
6.75 SEK
06 Apr - 23 Apr 2018
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
06 Apr - 23 Apr 2018
Subscription price
Price per share
6.75 SEK
Target to raise
15 800 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:4. Shareholders in Redwood Pharma receive one (1) subscription right for each existing share that the owner holds in the Company. Four (4) subscription rights entitle to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
New issue
7.25 SEK
91.96M SEK
04 Sep - 23 Sep 2019
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
04 Sep - 23 Sep 2019
Subscription price
7.25 SEK
Price per share
7.25 SEK
Target to raise
11 495 332 SEK
Types
Share issue
Pre-money valuation
91 962 698 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Active
Listing status
Listed
Issue terms
Pre-emption 1:8. The terms of the Rights Issue mean that eight (8) existing shares entitle the holder to subscribe for one (1) new share.
Comment for Offer
The reason for the issue is mainly to liquidate the remaining part of the convertible facility that has existed since 2018.

Type
Ticker
ISIN
Market
SHARE
REDW
SE0008294789
Spotlight
Sweden (SE)
Details of share in Redwood Pharma AB with ticker REDW
Status
Active
Order book id
4142
Amount of instruments
12 499 874
Par value
0.2000
Market cap
Currency
SEK
First trading date
15 Jun 2016
Terms
Type
Price
Pre-money valuation
Time
IPO
9.00 SEK
28.8M SEK
16 May - 27 May 2016
IPO in Redwood Pharma AB
Market
Spotlight
Subscription period
16 May - 27 May 2016
Subscription price
9.00 SEK
Price per share
9.00 SEK
Target to raise
19 800 000 SEK
Types
Pre-money valuation
28 800 000 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
15 Jun 2016
Issue terms
Without preferential rights.
Type
Price
Pre-money valuation
Time
New issue
3.30 SEK
16.5M SEK
01 Jun - 20 Jun 2017
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
01 Jun - 20 Jun 2017
Subscription price
3.30 SEK
Price per share
3.30 SEK
Target to raise
13 200 000 SEK
Types
Share issue
Pre-money valuation
16 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:5. Those who are registered as shareholders of Redwood Pharma on the record date for the Rights Issue receive one (1) unit right for each existing share that the owner holds in the Company. Five (5) unit rights entitle to subscribe for four (4) units. Each unit consists of one (1) newly issued share and one (1) newly issued warrant.
Type
Price
Pre-money valuation
Time
New issue
6.75 SEK
06 Apr - 23 Apr 2018
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
06 Apr - 23 Apr 2018
Subscription price
Price per share
6.75 SEK
Target to raise
15 800 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 1:4. Shareholders in Redwood Pharma receive one (1) subscription right for each existing share that the owner holds in the Company. Four (4) subscription rights entitle to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
New issue
7.25 SEK
91.96M SEK
04 Sep - 23 Sep 2019
Share issue in Redwood Pharma AB
Market
Spotlight
Subscription period
04 Sep - 23 Sep 2019
Subscription price
7.25 SEK
Price per share
7.25 SEK
Target to raise
11 495 332 SEK
Types
Share issue
Pre-money valuation
91 962 698 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Active
Listing status
Listed
Issue terms
Pre-emption 1:8. The terms of the Rights Issue mean that eight (8) existing shares entitle the holder to subscribe for one (1) new share.
Comment for Offer
The reason for the issue is mainly to liquidate the remaining part of the convertible facility that has existed since 2018.

Type
Ticker
ISIN
Market
OPTION
REDW TO 1
SE0008294904
Spotlight
Sweden (SE)
Details of option in Redwood Pharma AB with ticker REDW TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Exercise
10.35 SEK
-
01 Jun - 31 Aug 2017
Option exercise terms for REDW TO 1
Market
Spotlight
Exercise period(s)
01 Jun - 31 Aug 2017
Exercise price
10.35 SEK
Status
Closed
Issue terms
Type
Ticker
ISIN
Market
OPTION
REDW TO 2
SE0009994700
Spotlight
Sweden (SE)
Details of option in Redwood Pharma AB with ticker REDW TO 2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Type
Price
Pre-money valuation
Time
Exercise
5.52 SEK
-
02 Oct - 16 Oct 2017
Option exercise terms for REDW TO 2
Market
Spotlight
Exercise period(s)
02 Oct - 16 Oct 2017
Exercise price
5.52 SEK
Status
Closed
Issue terms
People
Martin Vidaeus
CEO
Gunnar Mattsson
Chairman of the board
Hans Ageland
Board member
Ingrid Atteryd-Heiman
Board member
Martin Vidaeus
Board member
Mats Lidgard
Board member
Company Details
Sector
HEALTH CARE

Address
Ringvagen 100E
Zip code
118 60
City/district
Stockholm
Country
Sweden (SE)
Registration number
556885-1280
LEI code
254900I6BC77A0F8I833
First trade date
15 Jun 2016
Registration date
23 Feb 2012
Short name
REDW